InxMed

InxMed (应世生物) is a clinical-stage biotechnology company that develops individualized medicines. It builds up a differentiated drug pipeline with the potential of intrinsic synergy to combat cancer, including uveal melanoma, gastric cancer, pancreatic cancer, etc.